Gene · 259197
Papers4,252
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,252
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis. | Biomedicines | 2023 | 38137450 | PubTator, text mining | PubMed |
| Unlocking Glioblastoma Secrets: Natural Killer Cell Therapy against Cancer Stem Cells. | Cancers (Basel) | 2023 | 38136381 | PubTator, text mining | PubMed |
| Therapeutic Targeting of Glioblastoma and the Interactions with Its Microenvironment. | Cancers (Basel) | 2023 | 38136335 | PubTator, text mining | PubMed |
| Immune Cells in the Tumor Microenvironment of Soft Tissue Sarcomas. | Cancers (Basel) | 2023 | 38136307 | PubTator, text mining | PubMed |
| Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis. | Pathogens | 2023 | 38133265 | PubTator, text mining | PubMed |
| ROS regulation in gliomas: implications for treatment strategies. | Front Immunol | 2023 | 38130720 | PubTator, text mining | PubMed |
| g-NK cells from umbilical cord blood are phenotypically and functionally different than g-NK cells from peripheral blood. | Oncoimmunology | 2023 | 38126036 | PubTator, text mining | PubMed |
| The effect of hypothyroidism on the risk of diabetes and its microvascular complications: a Mendelian randomization study. | Front Endocrinol (Lausanne) | 2023 | 38116309 | PubTator, text mining | PubMed |
| Suppression of NK Cell Activation by JAK3 Inhibition: Implication in the Treatment of Autoimmune Diseases. | J Immunol Res | 2023 | 38106519 | PubTator, text mining | PubMed |
| Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. | medRxiv | 2023 | 38105958 | PubTator, text mining | PubMed |
| Immunology of amyotrophic lateral sclerosis - role of the innate and adaptive immunity. | Front Neurosci | 2023 | 38105925 | PubTator, text mining | PubMed |
| The performance of VCS(volume, conductivity, light scatter) parameters in distinguishing latent tuberculosis and active tuberculosis by using machine learning algorithm. | BMC Infect Dis | 2023 | 38104064 | PubTator, text mining | PubMed |
| Mapping the protein-protein interactome in the tumor immune microenvironment. | Antib Ther | 2023 | 38098892 | PubTator, text mining | PubMed |
| Atypical B cells consist of subsets with distinct functional profiles. | iScience | 2023 | 38098745 | PubTator, text mining | PubMed |
| Role of the immune system in liver transplantation and its implications for therapeutic interventions. | MedComm (2020) | 2023 | 38098611 | PubTator, text mining | PubMed |
| Sex and gender affect immune aging. | Front Aging | 2023 | 38088954 | PubTator, text mining | PubMed |
| Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies. | J Immunother Cancer | 2023 | 38081778 | PubTator, text mining | PubMed |
| Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system. | Front Immunol | 2023 | 38077402 | PubTator, text mining | PubMed |
| Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy. | Front Immunol | 2023 | 38077389 | PubTator, text mining | PubMed |
| Editorial: Community series in the role of angiogenesis and immune response in tumor microenvironment of solid tumor: volume II. | Front Immunol | 2023 | 38077341 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/259197/papers?page=13